West Nile Virus

West Nile vaccine begins Phase I clinical study

Published in Vaccine Weekly, January 18th, 2006

Dutch biotechnology company Crucell N.V. (CRXL) has obtained approval from Belgian authorities to test the safety, tolerability, and immunogenicity of its whole-inactivated West Nile virus vaccine in healthy volunteers. This opens the way for the imminent commencement of a Phase I clinical trial, with recruitment of volunteers underway.

The clinical trial for the human West Nile vaccine follows the June 2004 Israeli market authorization for a veterinary vaccine developed earlier together with the Kimron Veterinary Institute for use in geese. The first large commercial group of geese were recently vaccinated successfully at Kimron with two doses of the PER.C6(R)-based...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2006-01-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry